Global 3D Printed Drugs Market 2018 Industry Key Players, Trends, Analysis & Forecast to 2025
Summary
Global 3D printed drugs market is valued approximately USD XX
Million in 2016 is anticipated to grow with a healthy growth rate of XX% over
the forecast period 2017-2025.
3D printed drugs are created by 3D printing technology which are used
to treat patients who 3suffering from dysphagia. This medicine is easy to
swallow and helpful for patients suffering from dysphagia.
Increase in demand for fast soluble drugs which
can disperse easily in the mouth is the key factor that gives growth to the global 3D printed drugs market.
Furthermore, rising incidence of epilepsy cases, continues technological
developments in 3D printing technique, and growing awareness for 3D printing
technology in the developing countries are the major drivers of the market.
However, concerns such as blueprint
hacking and mislabelling of blueprint are going to hamper the market growth. Moreover, dicey regulatory scenario is
another major restraint.
In 2016, Spritam is first 3D
printed drug receive approval from the FDA. It is launched by Aprecia
Pharmaceuticals. This medicine is currently active only in the U.S. region.
Request a sample market research
report with TOC:
The market
research report clearly defines market sizes of different segments &
countries in recent years and to forecast the values to the coming eight years.
The report is designed to incorporate both qualitative and quantitative aspects
of the 3D
printed drugs industry within each of the regions and countries
involved in the study. Furthermore, the report also caters the detailed
information about the crucial aspects such as driving factors & challenges
which will define the future growth of the market. Additionally, the report
shall also incorporate available opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive
landscape and product offerings of key players.
Market Segmentation of 3d Printed
drugs is given below:
Drugs:
- Spritam
- Others
Market segmentation by Region:
- North America
- U.S.
- Rest of the world
Years considered for the market
study are as follows:
- Historical year 2015
- Base year 2016
- Forecast period 2017 to 2025
Some 3D
Printed Drugs manufacturers are Aprecia Pharmaceuticals, GlaxoSmithKline
Plc., Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, and FabRx Ltd.
Acquisitions and effective mergers are some of the strategies adopted by the
key manufacturers. New product launches and continuous technological
innovations are the key strategies adopted by the major players.
Target Audience of the 3D printed drugs Market Study:







Browse market report: http://www.jsbmarketresearch.com/pharmaceuticals/global-3d-printed-drugs-market-size-study-by-drug-spritam-and-others-and-regional-us-and-rest-of-the-world-forecasts-2017-2025
Related Reports in 3D printing technology:
Global and
Chinese 3D printing Lab Equipment Industry, 2018 Market Research
Report
Global and
Chinese Metal Material Based 3D printing Industry, 2018 Market
Research Report
Global and
Chinese Medical 3D printing Industry, 2018 Market Research
Report
Global 3D printing &
Additive Manufacturing in the Aerospace & Defence Sales Market Report 2018
Global 3D
Printing in Dentistry Market Research Report 2018
United States
Commercial Aerospace 3D Printing Market Report 2017
Contact Us:
(+91)-9987295242
Comments
Post a Comment